Sangamo Therapeutics: Custom Services from Leading Supplier

We are pleased to announce an exciting collaboration between Sangamo Therapeutics and T&L Biotechnology Co., Ltd. to bring cutting-edge Gene Therapy products to the market. Our partnership aims to combine Sangamo's expertise in gene editing and T&L Biotechnology's innovative research and development capabilities to create groundbreaking treatments for a wide range of genetic diseases, One of the most promising products resulting from this collaboration is a gene therapy for a rare inherited disorder. This therapy aims to correct the underlying genetic mutation, providing a potential cure for patients suffering from this condition. Through the use of Sangamo's gene editing technology and T&L Biotechnology's manufacturing excellence, we are committed to delivering safe, effective, and accessible treatments for patients in need, This collaboration represents a significant advancement in the field of gene therapy, and we are excited about the potential impact it will have on the lives of patients and their families. We look forward to bringing this innovative product to market and making a meaningful difference in the lives of those affected by genetic diseases